LFCR241220P5000
- 0.05
- 0.000.00%
Lifecore Biomedical Newsroom
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $10
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Barrington Remains a Hold on Lifecore Biomedical (LFCR)
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $8
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Lifecore Biomedical: A Cautious Hold Amid Modest Growth and Financial Challenges
Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)
Stephens Maintains Lifecore Biomedical(LFCR.US) With Hold Rating, Cuts Target Price to $5
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Barrington Maintains Lifecore Biomedical(LFCR.US) With Hold Rating
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
Lifecore Biomedical Analyst Ratings
Craig-Hallum Initiates Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $8
Barrington Downgrades Lifecore Biomedical(LFCR.US) to Hold Rating
Stephens & Co. Maintains Equal-Weight on Lifecore Biomedical, Raises Price Target to $9
Lifecore Biomedical Analyst Ratings
Barrington Trims Price Target on Lifecore Biomedical to $10 From $11, Maintains Outperform Rating
Barrington Raises Price Target on Lifecore Biomedical to $11 From $10, Keeps Outperform Rating